期刊文献+

胆红素在恶性肿瘤中的功能新见解及相关研究进展 被引量:4

下载PDF
导出
摘要 胆红素是血红素的主要分解代谢产物之一,最初被认为是一种代谢废物。近期研究表明,血清胆红素水平与包括恶性肿瘤在内的多种慢性疾病的发生、发展相关,被认为是一种有价值的恶性肿瘤疗效、预后标志物。胆红素在恶性肿瘤中的重要价值一度被低估,对于胆红素这种传统标志物的研究可能为恶性肿瘤的发生机制带来新的见解,为其临床诊疗提供新思路。因此,本文对胆红素在恶性肿瘤中的功能和研究进展进行综述,为恶性肿瘤的诊治和评估提供启发。
出处 《牡丹江医学院学报》 2022年第2期126-129,共4页 Journal of Mudanjiang Medical University
基金 安徽省“十三五”医疗卫生重点培育专科建设项目(皖卫科教〔2017〕30号文件) 蚌埠医学院第一附属医院一般新技术项目(2020144) 蚌埠医学院研究生科研创新计划项目(Byycxz20045,Byycx20046)。
  • 相关文献

参考文献3

二级参考文献46

  • 1Jian-Ming Xu,Yan Wang,Fei-Jiao Ge,Li Lin,Ze-Yuan Liu,Manish R Sharma.Severe irinotecan-induced toxicity in a patient with UGT1A1*28 and UGT1A1*6 polymorphisms[J].World Journal of Gastroenterology,2013,19(24):3899-3903. 被引量:14
  • 2E.A. Eisenhauer,P. Therasse,J. Bogaerts,L.H. Schwartz,D. Sargent,R. Ford,J. Dancey,S. Arbuck,S. Gwyther,M. Mooney,L. Rubinstein,L. Shankar,L. Dodd,R. Kaplan,D. Lacombe,J. Verweij.New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)[J]. European Journal of Cancer . 2008 (2)
  • 3Peter S. Yoo,Reynold I. Lopez-Soler,Walter E. Longo,Charles H. Cha.Liver Resection for Metastatic Colorectal Cancer in the Age of Neoadjuvant Chemotherapy and Bevacizumab[J].Clinical Colorectal Cancer.2006(3)
  • 4Lindsey A. Torre,Freddie Bray,Rebecca L. Siegel,Jacques Ferlay,Joannie Lortet‐Tieulent,Ahmedin Jemal.Global cancer statistics, 2012[J]. CA: A Cancer Journal for Clinicians . 2015 (2)
  • 5Tournigand C,Andre T,Achille E,et al.FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. Journal of Clinical Oncology . 2004
  • 6Freyer G,Rougier P,Bugat R,Droz JP,Marty M,Bleiberg H,Mignard D,Awad L,Herait P,Culine S,Trillet-Lenoir V.Prognostic factors for tumour response progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11)as second-line chemotherapy after 5FU failure.CPT-11F205 F220 F221 and V222 study groups. British Journal of Cancer . 2000
  • 7Meyerhardt Jeffrey A,Kwok Ambrose,Ratain Mark J,McGovren J Patrick,Fuchs Charles S.Relationship of baseline serum bilirubin to efficacy and toxicity of single-agent irinotecan in patients with metastatic colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology . 2004
  • 8Dréanic J,Maillet M,Dhooge M,et al.Prognostic value of the Glasgow Prognostic Score in metastatic colorectal cancer in the era of anti-EGFR therapies. Medical Oncology . 2013
  • 9Loupakis F,Yang D,Yau L,Feng S,Cremolini C,Zhang W,Maus MK,Antoniotti C,Langer C,Scherer SJ,Müller T,Hurwitz HI,Saltz L,Falcone A,Lenz HJ.Primary tumor location as a prognostic factor in metastatic colorectal cancer. Journal of the National Cancer Institute . 2015
  • 10Junko Sugatani,Kasumi Yamakawa,Kouich Yoshinari,Takashi Machida,Hitoshi Takagi,Masatomo Mori,Satoru Kakizaki,Tatsuya Sueyoshi,Masahiko Negishi,Masao Miwa.??Identification of a Defect in the UGT1A1 Gene Promoter and Its Association with Hyperbilirubinemia(J)Biochemical and Biophysical Research Communications . 2002 (2)

共引文献673

同被引文献40

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部